Overview

Spironolactone for Paroxysmal Atrial Fibrillation

Status:
Unknown status
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
To determine whether or not spironolactone can prevent or delay the occurrence of atrial fibrillation.
Phase:
N/A
Details
Lead Sponsor:
Taichung Veterans General Hospital
Treatments:
Spironolactone